C12Y 304/14009
Tripeptidyl-peptidase i
Official title: Tripeptidyl-peptidase I (3.4.14.9)
C12Y304/14009 (Tripeptidyl-peptidase i) appears on 24 US grants and 53 published applications in this corpus.
Search patents in C12Y- Granted patents
- 24
- Published applications
- 53
- Assignees
- 16
- Inventors
- 79
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 2 | 0 |
| 2011 | 1 | 2 |
| 2012 | 2 | 2 |
| 2013 | 1 | 2 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 6 |
| 2018 | 1 | 4 |
| 2019 | 4 | 6 |
| 2020 | 1 | 4 |
| 2021 | 2 | 2 |
| 2022 | 3 | 6 |
| 2023 | 1 | 3 |
| 2024 | 1 | 3 |
| 2025 | 1 | 1 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Targeting peptides for directing adeno-associated viruses (AAVs)16 Jun 2026US 12,653,904 B2California Institute of Technology
- Gene therapy for ceroid lipofuscinoses30 Sep 2025US 12,428,653 B2The Trustees of the University of Pennsylvania
- Selective recovery19 Mar 2024US 11,932,668 B2California Institute of Technology
- Gene therapy for ceroid lipofuscinoses28 Feb 2023US 11,591,614 B2The Trustees of the University of Pennsylvania
- Targeting peptides for directing adeno-associated viruses (AAVs)15 Nov 2022US 11,499,165 B2California Institute of Technology
- Novel gene therapy construct for cln2 disease30 Jul 2026US 2026/0216378 A1The Children’s Hospital of Philadelphia
- Anti-Human Transferrin Receptor Antibody Permeating Blood-Brain Barrier2 Jul 2026US 2026/0184781 A1JCR Pharmaceuticals Co., Ltd.
- Gene therapy for ceroid lipofuscinoses19 Mar 2026US 2026/0078406 A1The Trustees of the University of Pennsylvania
- Methods for treating lysosomal storage diseases6 Nov 2025US 2025/0338833 A1Rutgers, The State University of New Jersey
- Methods for treating lysosomal storage diseases16 May 2024US 2024/0158772 A1Rutgers, The State University of New Jersey
Most cited
By later US patents
- Recombinant AAV capsid protein95US 9,585,971 B2California Institute of Technology · 2017
- Human lysosomal protein and methods of its use21US 6,302,685 B1University of Medicine and Dentistry of New Jersey · 2001
- Selective recovery11US 10,202,425 B2California Institute of Technology · 2019
- Selective recovery11US 9,957,303 B2California Institute of Technology · 2018
- Selective recovery8US 10,519,198 B2California Institute of Technology · 2019